ASCEND BY NTHRYS
Research Abroad Products

Transcriptomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 13–24 of 200 project topics
Immunotherapy Response Prediction Engine via Transcriptome Analysis
A proprietary tool that predicts patient response to checkpoint inhibitors and CAR-T therapies by analyzing immune-related gene expression patterns in tumor samples. Hospitals and oncology centers adopt this as a companion diagnostic service, creating recurring revenue through per-sample testing fees.
Cancer Transcriptomics Drug Target Discovery Click to view more details →
Personalized Cancer Drug Sensitivity Profiling Analytics Service
A cloud-based analytics service that profiles individual tumor transcriptomes to predict drug sensitivity across multiple therapeutic candidates in real-time. Precision medicine clinics integrate this service to offer patients personalized treatment recommendations, generating B2B2C revenue streams and increasing patient retention.
Cancer Transcriptomics Drug Target Discovery Click to view more details →
Synthetic Lethality Target Discovery Platform for Oncology
An integrated bioinformatics platform that identifies synthetic lethal partners for known cancer mutations through transcriptome-wide interaction mapping and computational modeling. Biotech companies license this platform to discover novel drug targets with reduced failure rates, commanding premium software licensing fees.
Cancer Transcriptomics Drug Target Discovery Click to view more details →
Circulating Tumor Cell Transcriptomics Liquid Biopsy Service
A commercial service that analyzes circulating tumor cell transcriptomes from blood samples to detect early-stage cancer and monitor treatment response without invasive biopsies. This positions providers as leaders in non-invasive diagnostics with high-volume testing capacity, generating substantial recurring clinical lab revenues.
Cancer Transcriptomics Drug Target Discovery Click to view more details →
Tumor Microenvironment Immune Profiling SaaS for Drug Discovery
A specialized SaaS platform that decodes immune cell composition and activation states within tumors through single-cell transcriptomic analysis and spatial mapping. Pharmaceutical companies use this to identify immunomodulatory drug targets and optimize combination therapy strategies, driving subscription and data licensing revenue.
Cancer Transcriptomics Drug Target Discovery Click to view more details →
Cancer Relapse Risk Stratification Tool Using Gene Expression
A clinical decision support tool that integrates tumor transcriptome signatures with patient clinical data to predict recurrence risk and guide adjuvant therapy selection. Hospitals adopt this platform to improve patient outcomes and reduce expensive retreatment costs, enabling SaaS licensing and outcome-based pricing models.
Cancer Transcriptomics Drug Target Discovery Click to view more details →
Multi-Cancer Type Driver Gene Identification and Validation Engine
An advanced bioinformatics engine that systematically identifies and ranks cancer driver genes across multiple tumor types using transcriptome-wide association analysis and functional genomics. Biotech and pharma companies purchase enterprise licenses to build internal target pipelines, reducing drug discovery costs and accelerating IND applications.
Cancer Transcriptomics Drug Target Discovery Click to view more details →
Epigenetic Silencing Biomarker Discovery Platform for Cancer Therapeutics
A specialized analytics platform that identifies epigenetically silenced tumor suppressor genes and predicts responsiveness to epigenetic drugs through transcriptomic profiling. Oncology biotech firms leverage this platform to de-risk drug development programs and secure regulatory approval for precision epigenetic therapies with defined biomarker populations.
Cancer Transcriptomics Drug Target Discovery Click to view more details →
RNA-Seq Disease Biomarker Panel Discovery Platform
A cloud-based SaaS platform that analyzes bulk and single-cell RNA-Seq data to identify and validate disease-specific gene expression signatures with clinical relevance. Enables pharmaceutical and diagnostic companies to develop companion diagnostic tests and accelerate drug development timelines, generating recurring licensing revenue.
Transcriptomics Biomarker Discovery Services Click to view more details →
Real-Time Liquid Biopsy Transcriptome Analysis Service
A commercial laboratory service that detects and quantifies circulating tumor RNA and cell-free RNA biomarkers from blood samples using rapid RT-qPCR and digital PCR workflows. Serves oncology clinics and cancer centers with actionable patient stratification data, creating high-margin per-sample revenue streams.
Transcriptomics Biomarker Discovery Services Click to view more details →
Personalized Medicine Transcript Profiling Engine SaaS
An AI-driven software platform that integrates patient RNA expression profiles with clinical metadata to predict drug response, toxicity risk, and optimal dosing regimens. Delivers precision medicine solutions to hospitals, pharmacies, and healthcare networks through subscription-based access and per-patient analysis fees.
Transcriptomics Biomarker Discovery Services Click to view more details →
Multi-Omics Cancer Progression Biomarker Detection Tool
A bioinformatics software tool that correlates RNA-Seq, mutation, and protein data to identify early cancer progression biomarkers and metastasis risk signatures. Positions oncology diagnostic companies to offer comprehensive tumor monitoring solutions with premium pricing and expanded clinical utility.
Transcriptomics Biomarker Discovery Services Click to view more details →